spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  allergic conjunctivitis 

 HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 24 Mar 2021
Johnson & Johnson Vision Receives Approval of World's First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE(R) Theravision(TM) with Ketotifen
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 9 Apr 2019
Bluejay Diagnostics, Inc. Announces CE Mark For Its Allereye(R) Tear Total IgE Test
Diagnostics Regulatory
 HSMN NewsFeed - 26 Mar 2019
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 29 Jan 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 24 Apr 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 May 2017
Bluejay Diagnostics' Board Of Directors Announces Appointment Of Douglas C. Wurth As Chairman
Diagnostics Personnel
 HSMN NewsFeed - 13 Oct 2016
Ocular Therapeutix(TM) and Regeneron Enter Into Strategic Collaboration to Develop Sustained Release Formulation of Aflibercept for the Treatment of Wet AMD and Other Serious Retinal Diseases
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Apr 2016
Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 25 Nov 2014
Eleven Biotherapeutics Announces Additional Financing of $20 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Feb 2011
Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Jan 2011
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2010
Inspire Announces Launch of DIQUASTM by Santen in Japan
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Nov 2010
ISTA Pharmaceuticals Granted Three-Year Market Exclusivity for BROMDAY
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2010
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
Inspire Elects George Abercrombie to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2010
Inspire Names Adrian Adams as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2009
Inspire Completes Patient Enrollment in Three Late-Stage Clinical Trials in Cystic Fibrosis, Dry Eye and Blepharitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 26 Jun 2009
Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 15 Jan 2009
ISTA Pharmaceuticals' New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2008
Inspire Announces Its Termination of Bilastine Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Dec 2007
Fovea Pharmaceuticals Completes EUR30M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Aug 2007
InSite Vision Announces U.S. Launch of AzaSite(TM) for Ocular Infections
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Jul 2007
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2007
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Jun 2007
Inspire and FAES Farma Amend Bilastine Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2007
Novagali Pharma Receives US FDA Orphan Drug Designation for Vekacia(R) for the Treatment of Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 8 May 2007
ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Apr 2007
Inspire Announces FDA Approval Of AzaSite(TM)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Apr 2007
U.S. Federal Circuit Court Affirms Judgment for Allergan, Inc. and Roche Palo Alto, LLC against Apotex, Inc., Apotex Corp., and Novex Pharma in Ketorolac Patent Infringement Lawsuit
Biopharmaceuticals Ophthalmology Generics Litigation
 HSMN NewsFeed - 4 Apr 2007
Novagali Pharma Announces Positive Vekacia(R) Clinical Results From Pivotal Phase III Trial in Vernal Keratoconjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Feb 2007
Inspire Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2007
Inspire Licenses AzaSite(TM) For Ocular Infections
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 16 Jan 2007
Inspire Provides Cystic Fibrosis Clinical Program Update
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) for Treatment of Allergy Disorders to iCo Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Jan 2007
Inspire Announces Dry Eye Program Update
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 21 Dec 2006
ISTA Pharmaceuticals Submits Investigational New Drug Application for Eye Drop Formulation of Bepotastine for the Treatment of Allergic Conjunctivitis
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Nov 2006
Inspire and FAES Farma Announce Licensing Agreement for New Oral Antihistamine to Target Allergy Market in United States and Canada
Biopharmaceuticals LIcensing
 HSMN NewsFeed - 20 Oct 2006
FDA Approves Prescription Zaditor(R) for Over-The-Counter Relief From Itchy Eyes
Biopharmaceuticals Ophthalmology FDA
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
allergic conjunctivitis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.